Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta‐analysis
暂无分享,去创建一个
Dario Pitocco | Francesco Zaccardi | Alessandro Rizzi | F. Zaccardi | G. Ghirlanda | D. Pitocco | B. Rocca | Giovanni Ghirlanda | Bianca Rocca | Luigi Tanese | A. Rizzi | L. Tanese
[1] J. Bessman. The relation of megakaryocyte ploidy to platelet volume , 1984, American journal of hematology.
[2] M. Keleş,et al. Association of Mean Platelet Volume With The Degree of Retinopathy in Patients with Diabetes Mellitus , 2009 .
[3] H. Hod,et al. Increased mean platelet volume is associated with non-responsiveness to clopidogrel , 2014, Thrombosis and Haemostasis.
[4] C. Patrono,et al. Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. , 2013, Blood.
[5] Mei Han,et al. Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. , 2011, International journal of ophthalmology.
[6] S. Uchiyama,et al. Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. , 2002, Thrombosis research.
[7] A. Abacı,et al. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients , 2010, Platelets.
[8] Yen-Lin Chen,et al. Association Between Platelet Count and Components of Metabolic Syndrome in Geriatric Taiwanese Males , 2012 .
[9] P. Sidhu,et al. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack , 2004, British journal of haematology.
[10] E. Coban,et al. The mean platelet volume in subjects with impaired fasting glucose , 2006, Platelets.
[11] J. Yudkin,et al. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. , 1988, Diabetes research and clinical practice.
[12] C. Watala,et al. Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity? , 1999, Platelets.
[13] M. Vaduganathan,et al. Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.
[14] J. González-Porras,et al. The role of immature platelet fraction in acute coronary syndrome , 2009, Thrombosis and Haemostasis.
[15] Ş. Bulur,et al. The relationship between mean platelet volume with metabolic syndrome in obese individuals , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[16] M. Lishner,et al. Are platelet volume indices of clinical use? A multidisciplinary review , 2012, Annals of medicine.
[17] R. Ravindran,et al. Increased Platelet Cholesterol and Decreased Percentage Volume of Platelets as a Secondary Risk Factor for Coronary Artery Disease , 2008, Pathophysiology of Haemostasis and Thrombosis.
[18] A. Abacı,et al. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. , 2007, Thrombosis research.
[19] L. Polonski,et al. Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. , 2014, Journal of diabetes and its complications.
[20] G. De Luca,et al. Diabetes, glucose control and mean platelet volume: a single-centre cohort study. , 2014, Diabetes research and clinical practice.
[21] B. Egan,et al. Platelet and White Blood Cell Counts Are Elevated in Patients With the Metabolic Syndrome , 2005, Journal of clinical hypertension.
[22] E. Grove,et al. The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes , 2012, Nature Reviews Cardiology.
[23] C. Patrono,et al. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. , 2012, Blood.
[24] R. Demirtunç,et al. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. , 2009, Journal of diabetes and its complications.
[25] Jin Hwa Kim,et al. The relationship between mean platelet volume and fasting plasma glucose differs with glucose tolerance status in a Korean general population: Gender differences , 2013, Platelets.
[26] E. Coban,et al. The relationship between levels of von Willebrand factor and mean platelet volume in subjects with isolated impaired fasting glucose , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[27] N. Akhtar,et al. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. , 2008, Singapore medical journal.
[28] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[29] F. Santilli,et al. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes , 2012, Journal of thrombosis and haemostasis : JTH.
[30] K. Kaushansky. Historical review: megakaryopoiesis and thrombopoiesis. , 2008, Blood.
[31] Z. Canturk,et al. The effect of metformin on mean platelet volume in dıabetıc patients , 2013, Platelets.
[32] N. Lakkis,et al. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. , 2004, Journal of the American College of Cardiology.
[33] C Briggs,et al. Continuing developments with the automated platelet count 1 , 2007, International journal of laboratory hematology.
[34] G. Davı̀,et al. In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus , 1999 .
[35] G. Antonakos,et al. Platelet Markers Correlate with Glycemic Indices in Diabetic, but Not Diabetic-Myelodysplastic Patients with Normal Platelet Count , 2010, Disease markers.
[36] G. Davı̀,et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. , 1999, Circulation.
[37] I. Hozo,et al. Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.
[38] E. Yengil,et al. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? , 2014, International journal of clinical and experimental medicine.
[39] Deepak L. Bhatt,et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.
[40] E. Trowbridge,et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. , 1983, Thrombosis research.
[41] M. Amini,et al. Mean platelet volume measurement, EDTA or citrate? , 2006, Hematology.
[42] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[43] G. Ertas,et al. A New Parameter Predicting Chronic Total Occlusion of Coronary Arteries , 2014, Angiology.
[44] A. Tall,et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. , 2013, Cell metabolism.
[45] S. Choi,et al. Immature platelet fraction in diabetes mellitus and metabolic syndrome. , 2013, Thrombosis research.
[46] S. Grundy. Pre-diabetes, metabolic syndrome, and cardiovascular risk. , 2012, Journal of the American College of Cardiology.
[47] D. Mikhailidis,et al. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina , 2007, Platelets.
[48] O. Uysal,et al. Mean Platelet Volume and Extent and Complexity of Coronary Artery Disease in Diabetic and Nondiabetic Patients With ST Elevation Myocardial Infarction , 2013, Angiology.
[49] T. Nakayama,et al. Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects , 2013, Journal of diabetes investigation.
[50] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[51] G. Tognoni,et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.
[52] R. Demirtunç,et al. Effects of Doxazosin and Amlodipine on Mean Platelet Volume and Serum Serotonin Level in Patients with Metabolic Syndrome , 2007, Clinical drug investigation.
[53] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.
[54] K. E. Kim,et al. Mean platelet volume in the normal state and in various clinical disorders. , 1986, Yonsei medical journal.
[55] V. Lakshmaiah,et al. Mean Platelet Volume in Type 2 Diabetes Mellitus , 2012, Journal of laboratory physicians.
[56] G. Davı̀,et al. Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.
[57] D. Mikhailidis,et al. Mean platelet volume in patients with type 2 diabetes mellitus , 2005, Platelets.
[58] M. Benn,et al. High platelet volume and increased risk of myocardial infarction: 39 531 participants from the general population , 2011, Journal of thrombosis and haemostasis : JTH.
[59] Z. Hekimsoy,et al. Mean platelet volume in Type 2 diabetic patients. , 2004, Journal of diabetes and its complications.
[60] J. Hoffmann. Reticulated platelets: analytical aspects and clinical utility , 2014, Clinical chemistry and laboratory medicine.
[61] Mario Plebani,et al. Automated blood cell counts: state of the art. , 2008, American journal of clinical pathology.
[62] F. Hu,et al. Exporting diabetes mellitus to Asia: the impact of Western-style fast food. , 2012, Circulation.
[63] D. Choi,et al. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus , 2013, Platelets.
[64] G. Davı̀,et al. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. , 2010, Blood.
[65] A. Kosar,et al. Elevated Concentrations of Soluble Adhesion Molecules and Large Platelets in Diabetic Patients: Are They Markers of Vascular Disease and Diabetic Nephropathy? , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[66] The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.
[67] G. Abalı,et al. Correlation of the Coronary Severity Scores and Mean Platelet Volume in Diabetes Mellitus , 2013, Advances in Therapy.
[68] I. Ustun,et al. Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.
[69] M. Marescotti,et al. Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans , 2013, Diabetes Care.
[70] Binita Shah,et al. The Relationship Between Diabetes Mellitus , Metabolic Syndrome , and Platelet Activity asMeasured byMean Platelet Volume The National Health and Nutrition Examination Survey , 1999 – 2004 , 2012 .
[71] Y. Henskens,et al. Do we need time adjusted mean platelet volume measurements? , 2010, Laboratory hematology : official publication of the International Society for Laboratory Hematology.
[72] M. El Haouari,et al. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. , 2008, Blood cells, molecules & diseases.
[73] E. Coban,et al. Platelet activation in subjects with impaired glucose tolerance , 2007, Platelets.
[74] H. Cinemre,et al. Mean platelet volume is associated with glycaemic control and retinopathy in patients with type 2 diabetes mellitus. , 2013, The West Indian medical journal.
[75] T. Suehiro,et al. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus. , 1994, Journal of atherosclerosis and thrombosis.
[76] G. De Luca,et al. Platelet distribution width and the extent of coronary artery disease: Results from a large prospective study , 2010, Platelets.
[77] H. Hammes,et al. Erratum: ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (European Heart Journal (2013) 34 (3035-3087) Doi:10.1093/eurheartj/eht108) , 2014 .